PATIENTTRAC LIMITED

Company Registration Number:
10196539 (England and Wales)

Unaudited abridged accounts for the year ended 30 May 2024

Period of accounts

Start date: 31 May 2023

End date: 30 May 2024

PATIENTTRAC LIMITED

Contents of the Financial Statements

for the Period Ended 30 May 2024

Balance sheet
Notes

PATIENTTRAC LIMITED

Balance sheet

As at 30 May 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 234,048 234,048
Investments: 4 13,705,302 13,705,302
Total fixed assets: 13,939,350 13,939,350
Current assets
Debtors:   8,403,645 8,399,500
Cash at bank and in hand: 252,000 252,000
Total current assets: 8,655,645 8,651,500
Net current assets (liabilities): 8,655,645 8,651,500
Total assets less current liabilities: 22,594,995 22,590,850
Total net assets (liabilities): 22,594,995 22,590,850
Capital and reserves
Called up share capital: 4,075,120 4,075,120
Other reserves: 18,442,617 18,442,617
Profit and loss account: 77,258 73,113
Shareholders funds: 22,594,995 22,590,850

The notes form part of these financial statements

PATIENTTRAC LIMITED

Balance sheet statements

For the year ending 30 May 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 24 March 2025
and signed on behalf of the board by:

Name: H Wayne Hayes Jr
Status: Director

The notes form part of these financial statements

PATIENTTRAC LIMITED

Notes to the Financial Statements

for the Period Ended 30 May 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

PATIENTTRAC LIMITED

Notes to the Financial Statements

for the Period Ended 30 May 2024

2. Employees

2024 2023
Average number of employees during the period 1 1

PATIENTTRAC LIMITED

Notes to the Financial Statements

for the Period Ended 30 May 2024

3. Tangible Assets

Total
Cost £
At 31 May 2023 234,048
At 30 May 2024 234,048
Net book value
At 30 May 2024 234,048
At 30 May 2023 234,048

PATIENTTRAC LIMITED

Notes to the Financial Statements

for the Period Ended 30 May 2024

4. Fixed investments

Investment/acquisition, Marketable securities and promissory notes/ debentures